National Beverage Corp. (FIZZ) Rallies 13.39% After Earnings

2026-07-02 · Stocks · QuoteReporter

Post Earning Analysis

National Beverage Corp. (FIZZ) Rallies 13.39% After Earnings

National Beverage Corp., a prominent player in the beverage industry, produces and markets a diverse range of drinks including sparkling waters and sodas under well-known brands like LaCroix and Faygo. The current investment case is to hold, primarily due to the company's stable market position and consistent performance in a competitive industry.

National Beverage Corp. has announced a special cash dividend alongside its fiscal year 2026 results, a move that underscores the company's robust financial health and commitment to returning value to shareholders. This strategic decision not only rewards shareholders but also signals confidence in the company's cash flow stability and future profitability. The declaration of a special dividend typically strengthens the bull case for a stock, as it often leads to increased investor interest and can boost the stock price in the near term.

In addition to the dividend announcement, National Beverage's fiscal Q4 earnings provide further insight into the company's operational performance. While the specific figures from the earnings report were not disclosed, the simultaneous release of positive fiscal results with the dividend announcement suggests a strong financial standing. This could further solidify investor confidence, supporting a bullish outlook for the stock.

Investors should now look towards the next quarterly earnings announcement as a critical catalyst. This will be key in confirming the sustainability of National Beverage's financial performance and its ability to maintain or possibly increase shareholder returns. A continuation of positive financial results could further validate the bullish sentiment, while any signs of weakening performance might challenge it.

The current price of the stock is $35.15, marking a significant increase today of approximately 13.39%. The Relative Strength Index (RSI) stands at 52.78, suggesting a neutral momentum without clear indications of overbought or oversold conditions. The Moving Average Convergence Divergence (MACD) is at -0.83, indicating a potential bearish momentum as it remains below zero.

Comparing the current price to moving averages, the stock is trading above the 50-day and 200-day moving averages by 0.47% and 1.09%, respectively, suggesting a mild bullish sentiment in the medium to long term. However, the proximity to these averages also points to a possible pivot or consolidation phase.

The stock is currently 26.6% below its 52-week high of $47.89 and 14.31% above its 52-week low of $30.75, indicating it is in the lower range of its yearly cycle but has recovered from its lowest points.

Overall, the price action and the position relative to key technical indicators suggest cautious optimism among investors, with the market sentiment appearing moderately positive as the stock stabilizes above key moving averages despite a bearish hint from the MACD.

Earnings Trend Table

The earnings per share (EPS) trend for the company under review shows a general trajectory of growth, albeit with some fluctuations. Starting from Q4 2022, the EPS increased from 0.39 to a peak of 0.61 in Q3 2024, indicating a growth phase. However, this peak was followed by a deceleration with EPS dropping to 0.49 in Q4 2024 and further to 0.42 in Q1 2025.

The turning point in this trend was Q3 2024, where the EPS reached its highest at 0.61, surpassing estimates. This peak was followed by a decline, suggesting potential operational or market challenges impacting profitability. Notably, the company missed EPS estimates in the two most recent quarters, with a -3.92% surprise in Q4 2024 and a -4.55% surprise in Q1 2025, indicating a deceleration in earnings growth.

This decelerating trend could undermine the investment thesis if it suggests an ongoing issue affecting earnings potential. Investors might be cautious, considering whether the recent misses are indicative of a deeper problem.

Looking forward, the trajectory of recent quarters places the next quarter's consensus at risk, especially if the underlying issues are not addressed. The company needs to demonstrate a return to meeting or exceeding EPS estimates to regain investor confidence.

Dividend Payments Table

The dividend profile of the company shows a positive trend with an increase in payouts over the years. The most recent dividend, as of June 24, 2024, is $3.25, up from $3.00 in December 2021, maintaining the same level since December 2020. This represents a growth from $1.45 in November 2018, marking a significant increase over a six-year period.

The compound annual growth rate (CAGR) of the dividend from December 2010 ($1.15) to June 2024 ($3.25) is approximately 9.8% over approximately 13.5 years, indicating a robust growth trajectory. This growth suggests a strong commitment to returning value to shareholders and could be a signal of management's confidence in the company's financial health.

However, without specific data on the company's free cash flow and payout ratio, it's challenging to fully assess the sustainability of these dividends. If the free cash flow comfortably covers the dividend payments, this would further enhance the attractiveness of this stock to income investors, especially when compared to alternatives like the 10-year Treasury yield. The consistent increase and recent raise in dividends could make this stock particularly appealing to those seeking growing income streams.

The most recent rating changes for the stock in question show a mix of downgrades and an upgrade, reflecting a somewhat divided sentiment among analysts. The latest action was by Jefferies on January 4, 2023, downgrading the stock from "Hold" to "Underperform" with a target price adjustment from $42 to $38. Prior to this, CFRA downgraded the stock on January 16, 2020, from "Hold" to "Sell," setting the target price at $40, down from $50. Earlier, on October 20, 2020, Jefferies upgraded the stock from "Underperform" to "Hold" with a target price of $85, indicating a more positive outlook at that time. The oldest in this set is from UBS on February 3, 2021, which downgraded the stock from "Neutral" to "Sell" with a target price of $92.

The consensus among these analysts appears somewhat bearish, with recent downgrades and lower target prices. The most bearish outlook comes from Jefferies with a target price of $38, suggesting significant downside potential if their analysis holds true. Given the range of target prices from $38 to $92, there is a notable disparity, which might indicate underlying uncertainties or differing views on the company's future performance.

Given this mixed sentiment and the significant range in target prices, investors might approach this stock with caution. The credibility of the most bearish target by Jefferies could depend on specific fundamentals not detailed here, such as deteriorating financials or market conditions. In this scenario, trusting the consensus might be risky without a deeper understanding of the company's potential challenges and growth prospects.

With a current price of $35.15 and a recent downgrade by Jefferies setting a target at $38, the stock shows a modest upside potential of +8.1%. This slight gap suggests that while there is some room for growth, the stock is largely approaching its fair valuation according to the latest analyst expectations. The trend in analyst ratings, with multiple downgrades over the past three years, indicates a cautious or bearish outlook on the stock's future performance.

The market may be underpricing the potential for operational improvements or strategic initiatives that could enhance the company's value beyond the modest expectations set by current analyst targets. This underpricing represents a second-order effect where the market's focus on past performance metrics might overshadow any forthcoming positive developments.

A critical forward catalyst to watch is the upcoming quarterly earnings report. Should the company report earnings that significantly exceed analyst expectations, it could lead to a reassessment of the stock's potential and drive a reevaluation of its target price, confirming or invalidating the current cautious market sentiment.